Pulse Biosciences Stock Price

0.22 (1.27%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Pulse Biosciences Inc PLSE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.22 1.27% 17.56 18:00:20
Open Price Low Price High Price Close Price Prev Close
17.45 16.77 17.56 17.56 17.34
Bid Price Ask Price Spread News
16.51 20.62 4.11 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
754 38,129 $ 17.23 $ 656,990 56,705 8.76 - 45.82
Last Trade Time Type Quantity Stock Price Currency
17:08:22 1 $ 17.56 USD

Pulse Biosciences Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 464.64M 26.46M 13.85M $ - $ - -2.15 -7.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 401.05k 46.10%

more financials information »

Pulse Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PLSE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week17.6318.0516.7717.4446,485-0.07-0.4%
1 Month18.6419.38616.7718.0341,771-1.08-5.79%
3 Months22.7524.2014.59419.6669,778-5.19-22.81%
6 Months21.8945.8214.59427.38112,068-4.33-19.78%
1 Year10.0745.828.7620.94101,2017.4974.38%
3 Years16.6545.825.1115.7381,7100.915.47%
5 Years4.4045.824.110418.98116,40513.16299.09%

Pulse Biosciences Description

Pulse Biosciences Inc is a medical therapy company which pursues the commercial introduction of its proprietary CellFX System utilizing its patent-protected Nano-Pulse Stimulation (NPS) platform technology. Through its proprietary CellFX System, the company can deliver a cell-focused effect on dysfunctional cells while preserving surrounding non-cellular tissue, a combination that may potentially lead to both improved efficacy and less collateral tissue damage.

Your Recent History
Pulse Bios..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.